Dr. Roser Vives Dilme

A brief history of the practice

Dr. Vives Dilme graduated in Medicine from the University of Barcelona and specialized in Urology at the San Carlos University Clinical Hospital in Madrid. During her training, she showed particular interest in the areas of Urologic Oncology and Andrology. She completed a residency in the Andrology and Reconstructive Surgery Unit at Bellvitge University Hospital (Barcelona) and subsequently earned a Master's degree, obtaining the title of Expert in Uro-Oncology. She currently also practices at the Infanta Leonor University Hospital (Madrid). In 2022, she obtained the European title and certification: Fellow of the European Board of Urology (FEBU). She is currently pursuing a PhD in Urologic Oncology at the Complutense University of Madrid.

Current specialization

Currently, she specializes in Urologic Oncology, Andrology and Endourology and the treatment of lithiasis.

Academic activities and membership in organizations

Currently, he is a member of the Spanish Association of Urology (AEU) and the European Association of Urology (EAU).

Scientific activity

2024     

• Vives Dilme R., Rivas JG., Fernández Hernández L., De la Parra Sánchez I., et al. Oncological outcomes in robot-assisted radical prostatectomy: the value of PSA density as a preoperative predictive factor. Ther Adv Urol 2024; 7;16:17562872241229250.
• Leung D., Castellani D., Nicoletti R., Vives Dilme R., Sierra JM., Serni S., et al. The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study. Eur Urol Oncol 2024; 6:S2588-9311(23)00294-8.

2023

• Preisser F., Abrams-Pompe RS., Stelwagen PJ., Böhmer D., Zattoni F., Magli A., Gómez Rivas J., Vives Dilme R., et al. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy – A Multicenter Study. Eur Urol 2023; 22:S0302-2838(23)02886-5.

2022

• Vives Dilme R., Gómez Rivas J., Fernández Hernández L., Ibáñez Vázquez L., Cacciamani GE., Puliatti S., Taratkin M., Checcucci E., Rivero Belenchón I., Kowalewski KF., Serrano Á., Moreno Sierra J. Improving oncological outcomes after robot-assisted radical prostatectomy: what novel tools do we have? Mini Invasive Surg 2022;6:53.
• Vives Dilme R., Gómez Rivas J., Campi R., Puente J., Moreno Sierra J. Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma. Robotic Surgery for Renal Cancer, 2022. Springer, 1st Ed; 24:237-245. ISBN: 978-3-031-10999-7.
• Gómez Rivas J., Fernández Hernández L., Puente Vázquez J., Vidal Casinello N., Galante Romo MI., Redondo González E., Senovilla Pérez JL., Abad López P., Sanmamed Salgado N., Vives Dilme R., Moreno Sierra J. Where Do We Stand in the Management of Oligometastatic Prostate Cancer? A Comprehensive Review. Cancers 2022; 14(8):2017.
• Jerez Izquierdo T., Gómez Rivas J., Zondervan Jeannelle P., Vives Dilme R., Rodríguez M., Enikeev D., Serrano Pascual Á., Moreno Sierra J. Diagnosis and Treatment of Small Renal Masses: Where Do We Stand? Curr Urol Rep 2022; 23(6):99-111.

2021

• Vives Dilme R., Gómez Rivas J., Campi R., Puente J., Jerez T., Enikeev D., Esperto F., Moreno Sierra J. Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: Is There Still a Debate? Curr Urol Rep. 2021; 22(11):54.
• Vives Dilme R., Galante Romo MI., Fernández Hernández L., Redondo González E., Galindo Herrero I., Senovilla Pérez JL., Ciappara Paniagua M., Fernández Montarroso L., Moreno Sierra J. Robotic radical prostatectomy in the 21th century: evolution of experience. Med Research Arch. 2021; 9 (5): 1-18.
• De la Parra I., Serrano Á., Vives R., Hermida J., Díez-Valladares LI., Barrera J., Cortés JA., González-Peramato P., Gómez Á., Moreno J. Sarcomatoid transformation of chromophobe renal cell carcinoma: an unusual pathology. Our experience, definition of therapeutic guidelines and review of literature. EJMO 2021; 5(4): 361-367.
• Fernández Hernández L., Redondo González E., Vives Dilme R., Vidal Casinello N., Puente Vázquez J., Fernández Montarroso L., Galante Romo MI., Moreno Sierra J. Update on the management of non-metastatic castration-resistant prostate cancer. Med Research Arch. 2021; 9 (3): 1-13.
• Gutiérrez Hidalgo B., Gómez Rivas J., De la Parra I., Vives Dilme R., Fernández Montarroso L., Moreno Sierra J. Strategies to reactivate urological activity during the COVID-19 pandemic. Bol Col Mex Urol. 2021; 36 (1):68-74.

2020

• Moreno Sierra J., Galante Romo MI., Senovilla Pérez JL., Redondo González E., Galindo Herrero I., Barrera Ortega J., Vives Dilme R., Ariño Irujo J., Fernández Montarroso L., Fernández Pérez C. “Oncological results of a da Vinci robot-assisted radical prostatectomy program in a cohort of 408 consecutive patients”. Actas Urol Esp. 2020; 44:179-86.
• Vives Dilme R., Galante Romo MI., Moreno Sierra J. “Radical cystectomy in bladder cancer”. Rev. Cancer 2020. Vol. 33 (4): 1-8.